2025 annual financial data

ProQR Therapeutics 2025 Net margin

Direct answer

Net margin was -265.21%.

Operating income was -42.15M EUR and net income was -40.52M EUR.
Operating cash flow was -50.71M EUR.

Get free ProQR Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15.28M EUR
Operating income
-42.15M EUR
Net income
-40.52M EUR
Operating cash flow
-50.71M EUR